Statistics
Player Statistics
Every FPL player — points, price, form, ownership and upcoming fixtures. Filter by team and position.
Name | Fixtures | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| £5.5m | 49.8% | 75 | 4.0 | 13.6 | 0 | 2 | 4 | 8,705 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £15.8m | 78.6% | 72 | 3.5 | 4.6 | 2 | 9 | 0 | -26,194 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.3m | 49.4% | 70 | 3.0 | 11.1 | 0 | 4 | 6 | 7,967 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 11.4% | 70 | 4.8 | 13.2 | 0 | 1 | 2 | 8,796 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.1m | 26.6% | 67 | 8.0 | 8.3 | 1 | 1 | 0 | 4,844 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.5m | 26.3% | 67 | 7.5 | 10.3 | 6 | 6 | 4 | 34,349 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.7m | 32.7% | 66 | 6.0 | 9.9 | 8 | 5 | 1 | 21,890 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.1m | 18.3% | 63 | 8.0 | 12.4 | 6 | 2 | 0 | 18,419 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 11.4% | 62 | 4.2 | 12.9 | 4 | 2 | 1 | 8,938 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.3m | 47.7% | 61 | 4.8 | 9.7 | 1 | 0 | 0 | -10,207 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £9.3m | 26.3% | 61 | 4.8 | 6.6 | 0 | 7 | 0 | 15,087 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 48.6% | 58 | 3.5 | 9.8 | 1 | 1 | 2 | -1,437 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 25.5% | 58 | 8.2 | 11.8 | 1 | 1 | 0 | 1,504 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 6.8% | 58 | 6.0 | 11.4 | 2 | 0 | 2 | 11,138 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 24.3% | 57 | 4.8 | 12.1 | 0 | 0 | 0 | 4,934 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.2m | 54.6% | 57 | 4.2 | 7.0 | 5 | 5 | 2 | 7,871 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £7.2m | 35.9% | 56 | 8.8 | 7.8 | 2 | 6 | 1 | 20,742 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 3.5% | 56 | 8.8 | 10.0 | 14 | 0 | 1 | 9,887 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.2m | 18.8% | 56 | 2.5 | 9.0 | 0 | 1 | 1 | -2,926 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 6.8% | 56 | 6.0 | 11.2 | 2 | 0 | 0 | 11,522 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 16.6% | 55 | 5.5 | 8.2 | 5 | 3 | 1 | 2,290 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 11.5% | 55 | 6.8 | 9.6 | 0 | 6 | 1 | 1,446 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 2.5% | 55 | 5.2 | 12.2 | 4 | 1 | 0 | 2,233 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £7.9m | 33.3% | 55 | 2.8 | 7.0 | 1 | 5 | 2 | -37,410 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £7.5m | 13.7% | 51 | 3.8 | 6.8 | 1 | 0 | 5 | 1,535 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 4.7% | 51 | 3.5 | 10.0 | 0 | 2 | 3 | 1,781 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £6.0m | 5.6% | 51 | 4.8 | 8.5 | 7 | 3 | 3 | -1,993 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.7m | 7.2% | 50 | 3.8 | 7.5 | 0 | 3 | 1 | 662 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £9.8m | 28.0% | 49 | 2.8 | 5.0 | 2 | 3 | 4 | -10,748 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 1.6% | 49 | 5.8 | 10.0 | 10 | 3 | 2 | 6,717 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.7m | 13.3% | 49 | 2.5 | 10.4 | 0 | 0 | 0 | -1,089 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.7m | 3.1% | 49 | 6.2 | 8.6 | 3 | 3 | 1 | 1,639 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.1m | 3.9% | 48 | 6.8 | 9.4 | 8 | 0 | 0 | 2,643 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 8.8% | 48 | 2.2 | 9.1 | 0 | 3 | 3 | -3,945 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 16.5% | 48 | 3.8 | 8.0 | 9 | 4 | 2 | 14,800 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.8m | 9.3% | 47 | 1.5 | 8.1 | 0 | 3 | 4 | -5,752 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.6m | 28.5% | 47 | 0.0 | 6.2 | 0 | 5 | 3 | -24,234 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.2m | 16.9% | 47 | 3.0 | 9.0 | 1 | 1 | 1 | -5,657 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 15.9% | 47 | 6.0 | 10.7 | 7 | 0 | 0 | 3,781 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 12.1% | 46 | 1.5 | 7.5 | 0 | 3 | 2 | -6,486 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 2.5% | 46 | 3.8 | 8.4 | 0 | 3 | 1 | -199 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.3m | 7.0% | 46 | 5.2 | 6.3 | 0 | 1 | 5 | 10,337 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.8m | 17.9% | 46 | 1.2 | 5.9 | 0 | 4 | 1 | 462 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 4.9% | 45 | 4.2 | 8.2 | 1 | 2 | 4 | 1,935 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 20.2% | 45 | 1.0 | 8.0 | 1 | 1 | 4 | -29,287 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £11.6m | 20.0% | 45 | 3.0 | 3.9 | 0 | 4 | 2 | 2,425 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £7.8m | 5.6% | 45 | 2.0 | 5.8 | 0 | 1 | 4 | 1,760 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.7% | 44 | 2.5 | 9.8 | 0 | 0 | 1 | 116 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 1.2% | 44 | 4.0 | 9.8 | 0 | 0 | 2 | -336 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.1m | 4.8% | 44 | 3.5 | 8.6 | 0 | 0 | 0 | 935 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 4.8% | 44 | 5.2 | 8.0 | 0 | 0 | 0 | 2,614 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 2.0% | 44 | 7.5 | 9.2 | 11 | 0 | 0 | 618 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 2.2% | 43 | 3.0 | 7.8 | 0 | 0 | 0 | -115 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.7m | 0.5% | 43 | 5.2 | 7.5 | 15 | 4 | 0 | 21,489 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.4m | 14.4% | 43 | 3.5 | 6.7 | 0 | 0 | 0 | 907 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 4.0% | 42 | 2.5 | 7.8 | 0 | 0 | 3 | -2,564 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 3.9% | 42 | 3.0 | 9.3 | 0 | 1 | 0 | -774 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £6.6m | 4.8% | 42 | 2.0 | 6.4 | 1 | 3 | 1 | -5,538 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.6m | 2.5% | 42 | 3.5 | 9.1 | 0 | 0 | 1 | -347 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.2m | 11.7% | 42 | 3.0 | 10.0 | 0 | 1 | 0 | -1,929 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 4.1% | 42 | 3.0 | 7.6 | 0 | 0 | 0 | 964 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.2m | 8.8% | 41 | 2.8 | 6.6 | 1 | 2 | 3 | 2,534 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 1.5% | 41 | 3.0 | 9.1 | 0 | 1 | 0 | 44 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 4.3% | 41 | 3.8 | 9.1 | 2 | 0 | 0 | -432 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 1.4% | 41 | 3.0 | 7.6 | 1 | 1 | 1 | -675 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.5m | 0.5% | 41 | 5.5 | 7.5 | 6 | 1 | 1 | 918 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 2.8% | 41 | 3.2 | 7.6 | 2 | 2 | 1 | -1,533 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £7.8m | 8.9% | 41 | 2.8 | 5.3 | 2 | 1 | 3 | -1,895 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.4m | 5.8% | 40 | 4.2 | 5.4 | 5 | 3 | 1 | -421 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 40 | 6.0 | 6.8 | 9 | 2 | 2 | 4,485 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.3% | 40 | 3.8 | 7.3 | 12 | 2 | 3 | 306 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 1.1% | 40 | 5.2 | 7.3 | 2 | 2 | 2 | -266 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £7.1m | 7.0% | 40 | 2.0 | 5.6 | 0 | 1 | 3 | -236 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 3.4% | 39 | 6.0 | 7.2 | 6 | 0 | 1 | 572 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 1.7% | 39 | 1.5 | 7.1 | 0 | 2 | 1 | -776 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 8.4% | 39 | 2.8 | 7.1 | 0 | 0 | 0 | -330 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 5.3% | 39 | 2.8 | 6.7 | 2 | 0 | 4 | -4,298 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 12.5% | 39 | 0.5 | 6.6 | 2 | 1 | 1 | -5,317 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 3.5% | 39 | 4.2 | 6.3 | 10 | 1 | 1 | 1,819 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 2.9% | 39 | 4.2 | 9.1 | 1 | 0 | 2 | -1,162 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.6% | 38 | 2.0 | 7.6 | 2 | 1 | 3 | -296 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 6.4% | 38 | 1.8 | 9.3 | 0 | 0 | 0 | -1,887 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 1.7% | 38 | 5.5 | 6.9 | 0 | 2 | 3 | -130 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.7% | 38 | 3.8 | 7.2 | 7 | 0 | 2 | 110 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £9.4m | 5.2% | 37 | 0.0 | 3.9 | 0 | 3 | 0 | -1,871 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.4% | 37 | 3.2 | 7.4 | 3 | 0 | 1 | -51 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.1m | 3.4% | 37 | 2.8 | 7.3 | 6 | 0 | 0 | 3,727 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 1.6% | 37 | 1.8 | 7.4 | 0 | 2 | 0 | -425 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.2% | 37 | 3.0 | 8.2 | 1 | 0 | 1 | -107 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £8.2m | 5.3% | 37 | 0.0 | 4.5 | 0 | 2 | 3 | -1,944 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 1.4% | 37 | 4.5 | 7.0 | 8 | 0 | 0 | 51 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 3.3% | 36 | 5.2 | 8.0 | 6 | 0 | 0 | 612 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.5% | 36 | 3.8 | 8.0 | 4 | 0 | 0 | 292 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 5.8% | 35 | 2.8 | 7.0 | 0 | 0 | 0 | -597 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 6.9% | 35 | 1.0 | 8.8 | 3 | 0 | 0 | -1,097 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 2.7% | 35 | 1.2 | 6.5 | 1 | 2 | 1 | -1,521 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 7.0% | 35 | 1.5 | 6.5 | 2 | 0 | 0 | -3,549 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.4% | 35 | 2.8 | 7.0 | 5 | 2 | 1 | -184 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.9m | 4.9% | 35 | 3.0 | 7.1 | 1 | 1 | 1 | -1,935 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 2.0% | 35 | 2.0 | 6.4 | 0 | 0 | 1 | -400 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 6.4% | 34 | 2.5 | 7.6 | 0 | 1 | 0 | -1,231 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 4.5% | 34 | 1.5 | 7.7 | 1 | 2 | 0 | -1,668 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 4.4% | 34 | 1.5 | 8.3 | 0 | 1 | 0 | -630 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 1.6% | 34 | 0.8 | 5.7 | 1 | 1 | 0 | -297 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 1.9% | 34 | 2.2 | 6.4 | 0 | 0 | 1 | -1,939 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.3m | 2.5% | 33 | 4.5 | 5.2 | 3 | 1 | 0 | -194 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.4% | 33 | 3.0 | 5.6 | 10 | 2 | 2 | 433 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 1.2% | 33 | 3.5 | 7.5 | 1 | 0 | 0 | -262 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 2.3% | 33 | 2.0 | 6.2 | 0 | 0 | 1 | -2,937 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.4m | 5.6% | 32 | 2.0 | 5.9 | 0 | 0 | 2 | -1,684 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.1% | 32 | 3.2 | 6.4 | 1 | 0 | 1 | -36 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.2m | 1.6% | 32 | 4.5 | 7.6 | 5 | 0 | 0 | -159 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.7m | 4.1% | 32 | 2.0 | 5.6 | 0 | 3 | 1 | -5,701 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.6% | 31 | 5.5 | 6.3 | 3 | 2 | 2 | 1,410 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 31 | 3.5 | 6.9 | 3 | 0 | 0 | 9 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 2.4% | 31 | 1.0 | 7.8 | 0 | 0 | 1 | -814 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 2.7% | 31 | 1.8 | 7.8 | 3 | 1 | 0 | -466 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.6m | 1.1% | 31 | 1.8 | 5.5 | 0 | 1 | 1 | -120 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 1.1% | 31 | 3.8 | 6.2 | 1 | 0 | 0 | -311 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 1.7% | 31 | 4.5 | 5.8 | 1 | 3 | 0 | 235 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.1% | 31 | 3.2 | 5.6 | 4 | 0 | 0 | -24 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 4.0% | 31 | 3.0 | 6.2 | 0 | 0 | 0 | -1,413 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 30 | 5.2 | 4.8 | 8 | 2 | 1 | 949 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.7m | 2.1% | 30 | 2.2 | 4.5 | 2 | 2 | 0 | -739 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 30 | 0.5 | 5.1 | 1 | 1 | 1 | -454 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 2.1% | 30 | 0.0 | 5.1 | 0 | 1 | 2 | -27 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £7.8m | 6.7% | 30 | 3.0 | 3.8 | 0 | 2 | 3 | -6,574 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 1.4% | 30 | 1.2 | 7.5 | 0 | 1 | 1 | -415 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.5% | 30 | 2.5 | 6.1 | 3 | 0 | 0 | -58 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.3m | 0.6% | 30 | 2.2 | 5.7 | 1 | 0 | 1 | -128 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 0.5% | 30 | 2.2 | 5.5 | 0 | 1 | 1 | -158 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 30 | 3.5 | 6.0 | 3 | 0 | 0 | 7 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 30 | 3.5 | 6.7 | 4 | 0 | 0 | 57 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.5m | 2.0% | 30 | 1.5 | 5.5 | 2 | 0 | 0 | -735 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 1.1% | 30 | 1.0 | 5.5 | 0 | 0 | 1 | 34 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 0.5% | 30 | 1.2 | 5.5 | 1 | 2 | 0 | -240 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.6m | 2.5% | 30 | 3.5 | 4.5 | 2 | 0 | 3 | -921 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 29 | 4.8 | 6.4 | 6 | 0 | 0 | 152 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.3% | 29 | 3.2 | 5.8 | 3 | 0 | 0 | -21 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.3m | 1.2% | 29 | 0.2 | 6.7 | 0 | 0 | 0 | -202 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 1.3% | 29 | 1.5 | 5.9 | 2 | 2 | 1 | -791 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.3% | 29 | 2.8 | 6.0 | 4 | 0 | 1 | 36 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 6.3% | 29 | 0.8 | 7.2 | 1 | 2 | 2 | -3,089 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 1.1% | 29 | 2.5 | 7.2 | 0 | 1 | 3 | -93 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 29 | 2.5 | 6.4 | 1 | 0 | 1 | 65 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.3% | 29 | 3.0 | 5.9 | 2 | 0 | 2 | -16 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 13.4% | 29 | 2.0 | 4.3 | 0 | 1 | 1 | 623 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 1.0% | 29 | 4.0 | 6.6 | 0 | 0 | 2 | -330 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 1.3% | 29 | 2.8 | 5.0 | 7 | 2 | 1 | -155 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.8% | 28 | 2.0 | 6.2 | 2 | 0 | 1 | -205 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.3% | 28 | 2.2 | 5.6 | 0 | 0 | 1 | -105 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 28 | 2.2 | 5.6 | 3 | 0 | 0 | -14 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 5.0% | 28 | 4.8 | 5.3 | 12 | 0 | 1 | 3,068 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.6m | 0.7% | 28 | 4.8 | 5.0 | 4 | 0 | 1 | -18 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 28 | 4.5 | 6.4 | 6 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 28 | 3.2 | 5.8 | 3 | 0 | 0 | -36 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.9m | 0.2% | 27 | 1.2 | 4.6 | 0 | 1 | 2 | -95 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.9% | 27 | 2.0 | 5.4 | 4 | 0 | 3 | -433 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.2m | 0.1% | 27 | 2.8 | 5.2 | 1 | 2 | 1 | -18 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 1.4% | 27 | 3.2 | 5.0 | 0 | 1 | 0 | 108 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.5m | 0.6% | 27 | 0.2 | 4.2 | 0 | 2 | 1 | -123 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.5m | 4.4% | 27 | 2.0 | 3.6 | 2 | 1 | 2 | -5,376 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.7% | 27 | 0.2 | 5.4 | 1 | 1 | 0 | -173 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.2% | 27 | 3.0 | 6.1 | 6 | 0 | 1 | -13 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 26 | 1.5 | 5.8 | 0 | 0 | 0 | -464 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 0.4% | 26 | 4.2 | 4.2 | 0 | 1 | 1 | 33 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.1% | 26 | 0.0 | 5.8 | 0 | 1 | 1 | -503 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.2% | 26 | 3.2 | 5.9 | 1 | 1 | 0 | 27 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 2.5% | 26 | 6.0 | 6.7 | 6 | 0 | 1 | 426 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.0m | 0.1% | 25 | 3.8 | 5.0 | 3 | 0 | 1 | 23 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.6% | 25 | 0.8 | 4.2 | 0 | 3 | 0 | -117 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 2.5% | 25 | 0.8 | 5.7 | 0 | 2 | 0 | -1,328 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.5% | 25 | 1.5 | 5.6 | 0 | 0 | 3 | -427 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.5% | 25 | 2.8 | 5.6 | 1 | 0 | 0 | -26 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.0m | 0.2% | 25 | 2.0 | 4.2 | 0 | 0 | 0 | -64 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 3.1% | 25 | 1.8 | 4.3 | 1 | 1 | 0 | -2,415 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.6% | 25 | 2.0 | 6.2 | 0 | 0 | 0 | -39 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 1.8% | 25 | 2.2 | 4.7 | 0 | 0 | 0 | -155 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £8.1m | 4.4% | 25 | 3.0 | 3.1 | 0 | 0 | 3 | 1,132 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 1.3% | 25 | 2.5 | 5.1 | 7 | 1 | 0 | -235 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 1.3% | 25 | 1.8 | 5.0 | 2 | 0 | 0 | -243 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.0m | 2.5% | 25 | 1.8 | 3.6 | 1 | 1 | 0 | -4,246 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.2% | 25 | 2.8 | 5.1 | 1 | 1 | 0 | -84 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.2% | 24 | 2.8 | 4.8 | 1 | 1 | 1 | -41 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 4.2% | 24 | 0.8 | 4.1 | 0 | 0 | 1 | -2,064 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.2% | 24 | 0.8 | 4.8 | 1 | 1 | 0 | -76 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 4.2% | 24 | 1.5 | 5.3 | 0 | 0 | 1 | -1,271 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.9m | 3.5% | 24 | 1.8 | 3.5 | 1 | 1 | 0 | -2,553 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 24 | 2.2 | 4.4 | 0 | 0 | 1 | -58 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.6m | 0.3% | 24 | 3.8 | 4.3 | 0 | 1 | 0 | -1,256 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 3.8% | 23 | 1.8 | 3.8 | 1 | 0 | 2 | -683 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.1% | 23 | 4.8 | 4.6 | 0 | 1 | 1 | 67 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.8m | 2.1% | 23 | 1.2 | 3.4 | 2 | 1 | 2 | -1,255 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 2.2% | 23 | 1.2 | 3.8 | 1 | 2 | 0 | -254 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.9m | 7.5% | 23 | 1.2 | 3.9 | 1 | 1 | 1 | -4,200 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 0.4% | 23 | 4.5 | 4.0 | 5 | 1 | 2 | 166 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.4% | 22 | 0.0 | 4.9 | 0 | 0 | 1 | -116 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.3% | 22 | 3.5 | 4.4 | 2 | 0 | 1 | 106 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.2% | 22 | 2.2 | 5.5 | 3 | 1 | 0 | -5 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.2% | 22 | 1.2 | 4.2 | 1 | 1 | 0 | -49 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.9m | 0.9% | 22 | 0.8 | 3.7 | 0 | 0 | 0 | -667 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 0.1% | 22 | 4.5 | 3.7 | 1 | 1 | 1 | 79 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 0.1% | 22 | 1.0 | 4.4 | 0 | 1 | 1 | -41 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.2% | 21 | 2.0 | 4.7 | 8 | 0 | 0 | 443 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 3.0% | 21 | 0.2 | 4.3 | 1 | 0 | 0 | 176 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 6.8% | 21 | 2.0 | 5.4 | 1 | 0 | 1 | -852 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.1% | 21 | 4.2 | 4.4 | 7 | 2 | 0 | 196 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 0.3% | 21 | 4.2 | 3.9 | 5 | 2 | 0 | 39 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.3% | 21 | 4.2 | 4.0 | 8 | 2 | 0 | 479 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £3.9m | 9.6% | 21 | 1.0 | 5.4 | 0 | 0 | 0 | -1,787 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.1% | 21 | 3.8 | 4.4 | 1 | 1 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.5% | 21 | 2.0 | 4.2 | 0 | 0 | 0 | -88 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 7.0% | 21 | 1.2 | 4.4 | 0 | 0 | 0 | -1,048 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 21 | 2.8 | 3.7 | 0 | 1 | 2 | -38 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.7% | 21 | 1.0 | 3.9 | 2 | 1 | 1 | -148 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 20 | 2.2 | 4.1 | 1 | 0 | 1 | -41 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.1% | 20 | 0.8 | 3.6 | 0 | 1 | 1 | -8 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.9% | 20 | 2.2 | 4.2 | 0 | 0 | 0 | -275 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 20 | 1.2 | 4.2 | 1 | 0 | 0 | -20 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 20 | 0.8 | 4.0 | 2 | 0 | 1 | -7 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.2m | 0.1% | 20 | 1.8 | 3.8 | 1 | 1 | 1 | -13 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 1.2% | 20 | 2.5 | 3.8 | 2 | 0 | 0 | -151 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 1.0% | 19 | 3.5 | 3.1 | 10 | 1 | 0 | 60 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.3% | 19 | 0.5 | 3.6 | 0 | 0 | 1 | -31 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 19 | 3.5 | 4.2 | 0 | 0 | 0 | 42 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.1% | 19 | 1.5 | 4.0 | 0 | 0 | 0 | -82 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.4% | 19 | 1.2 | 3.8 | 1 | 1 | 1 | -240 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.1% | 19 | 1.0 | 3.9 | 4 | 0 | 1 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.2m | 0.3% | 19 | 2.8 | 3.7 | 7 | 1 | 0 | -12 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.3m | 3.3% | 18 | 1.0 | 4.2 | 0 | 0 | 0 | -1,992 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.4% | 18 | 0.0 | 4.0 | 0 | 0 | 0 | -57 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 18 | 2.2 | 4.1 | 5 | 0 | 0 | 308 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.4% | 18 | 2.0 | 3.3 | 1 | 1 | 1 | -74 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.1% | 18 | 1.5 | 3.3 | 1 | 0 | 2 | -20 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.5m | 0.1% | 18 | 0.8 | 3.3 | 2 | 0 | 0 | 5 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 0.2% | 18 | 1.2 | 3.4 | 3 | 1 | 0 | -17 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.3% | 17 | 3.2 | 3.9 | 7 | 0 | 0 | 269 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 8.0% | 17 | 1.0 | 2.7 | 2 | 0 | 0 | -1,103 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.2m | 4.0% | 17 | 2.2 | 3.3 | 0 | 0 | 1 | -1,129 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.9m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -52 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.7m | 0.4% | 16 | 0.2 | 3.4 | 0 | 1 | 1 | -83 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -22 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.1% | 16 | 1.2 | 3.3 | 0 | 0 | 1 | -8 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.1% | 16 | 1.0 | 2.9 | 2 | 2 | 0 | -33 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £6.1m | 1.1% | 16 | 2.5 | 2.6 | 4 | 0 | 1 | -20 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 1.2% | 16 | 1.0 | 3.4 | 0 | 0 | 0 | -143 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.6m | 4.6% | 16 | 0.0 | 3.5 | 0 | 0 | 1 | -1,929 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.3% | 16 | 1.8 | 3.6 | 6 | 0 | 0 | 25 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 16 | 0.8 | 2.6 | 2 | 1 | 0 | -81 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.5m | 1.1% | 15 | 3.0 | 2.3 | 1 | 0 | 0 | 539 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 1.0% | 15 | 2.2 | 2.8 | 1 | 0 | 0 | -362 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 15 | 1.2 | 3.1 | 1 | 1 | 0 | -31 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.8m | 0.1% | 15 | 0.8 | 2.6 | 0 | 0 | 0 | -25 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.9m | 0.0% | 15 | 1.8 | 3.1 | 0 | 0 | 0 | -5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.5% | 15 | 2.2 | 3.4 | 3 | 0 | 0 | 18 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.7% | 15 | 3.2 | 3.1 | 2 | 0 | 0 | 76 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.7% | 15 | 0.8 | 2.8 | 1 | 0 | 0 | -28 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 14 | 0.8 | 2.6 | 1 | 0 | 0 | -82 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 14 | 3.2 | 2.9 | 0 | 0 | 0 | 41 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.4m | 0.1% | 14 | 1.5 | 2.6 | 0 | 0 | 1 | -8 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.2m | 0.4% | 14 | 0.8 | 2.7 | 0 | 0 | 2 | -50 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.2% | 14 | 1.0 | 2.9 | 1 | 0 | 1 | -12 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 14 | 2.5 | 2.6 | 2 | 0 | 1 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 14 | 0.8 | 2.6 | 0 | 0 | 1 | -30 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.7m | 0.1% | 14 | 1.5 | 3.0 | 1 | 0 | 0 | 13 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.1% | 14 | 0.2 | 2.6 | 0 | 0 | 0 | -13 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 14 | 3.5 | 3.2 | 12 | 1 | 1 | 6,025 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.7m | 0.9% | 14 | 0.0 | 3.0 | 0 | 0 | 0 | -248 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.1% | 13 | 1.0 | 2.4 | 0 | 0 | 1 | -14 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 0.1% | 13 | 3.0 | 2.2 | 2 | 1 | 0 | 55 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.1% | 13 | 0.5 | 2.7 | 1 | 0 | 0 | -17 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.1% | 13 | 0.2 | 2.9 | 0 | 0 | 0 | -38 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.3% | 13 | 2.5 | 2.7 | 0 | 0 | 0 | -16 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 13 | 0.8 | 2.6 | 0 | 1 | 0 | -15 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.0% | 13 | 0.0 | 2.4 | 0 | 0 | 1 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.4% | 13 | 1.0 | 2.5 | 0 | 0 | 1 | -104 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.5% | 13 | 1.0 | 2.7 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.6m | 1.1% | 13 | 0.2 | 2.3 | 1 | 1 | 0 | 9 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.7m | 2.8% | 13 | 2.0 | 2.3 | 8 | 0 | 0 | 22 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.1m | 1.1% | 12 | 0.0 | 2.4 | 0 | 0 | 0 | -142 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 0.4% | 12 | 1.5 | 2.1 | 1 | 0 | 0 | -46 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.8% | 12 | 1.8 | 1.9 | 2 | 0 | 0 | -100 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.0% | 12 | 3.0 | 2.2 | 2 | 1 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 1.0% | 12 | 1.8 | 2.4 | 2 | 0 | 0 | -24 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.8% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | -285 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 3.0% | 12 | 0.0 | 2.9 | 0 | 0 | 1 | -1,061 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.2% | 12 | 2.5 | 2.4 | 0 | 0 | 0 | -28 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £7.0m | 2.9% | 11 | 1.8 | 1.6 | 0 | 0 | 1 | -367 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.0m | 0.1% | 11 | 1.8 | 1.8 | 1 | 0 | 1 | -53 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.0% | 11 | 2.5 | 2.3 | 0 | 1 | 0 | -29 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.4m | 0.8% | 11 | 0.2 | 2.0 | 0 | 0 | 0 | -376 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 11 | 2.5 | 2.5 | 1 | 0 | 0 | 13 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 11 | 0.8 | 2.6 | 2 | 1 | 0 | 6 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.8m | 0.8% | 11 | 0.8 | 1.9 | 0 | 0 | 1 | -245 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.8m | 0.9% | 11 | 0.0 | 1.6 | 0 | 0 | 0 | -272 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.1% | 11 | 0.2 | 1.9 | 0 | 1 | 0 | -8 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.4m | 0.3% | 11 | 0.2 | 1.7 | 1 | 0 | 0 | -128 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.7% | 10 | 0.2 | 2.3 | 0 | 0 | 0 | -241 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.8m | 0.7% | 10 | 1.0 | 1.7 | 1 | 0 | 0 | -168 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.5% | 10 | 2.0 | 1.9 | 0 | 0 | 0 | -92 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 10 | 0.2 | 1.9 | 0 | 0 | 0 | -24 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.5% | 10 | 0.0 | 2.1 | 0 | 1 | 0 | -201 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 10 | 1.2 | 1.9 | 0 | 0 | 0 | -6 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.5m | 0.4% | 10 | 0.0 | 1.5 | 0 | 0 | 0 | -61 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £3.9m | 0.5% | 10 | 1.2 | 2.6 | 0 | 0 | 0 | 2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.5% | 10 | 1.2 | 2.1 | 0 | 0 | 0 | -75 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.2m | 1.3% | 10 | 0.5 | 2.4 | 1 | 0 | 0 | -424 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 10 | 0.0 | 1.9 | 0 | 0 | 0 | -62 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 0.2% | 10 | 2.2 | 2.3 | 5 | 0 | 0 | 34 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.1% | 9 | 0.5 | 2.0 | 0 | 0 | 0 | -51 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 9 | 0.2 | 2.0 | 0 | 1 | 0 | -45 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 0.0% | 9 | 1.5 | 1.7 | 1 | 0 | 0 | -4 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 0.1% | 9 | 2.2 | 1.8 | 8 | 1 | 0 | 320 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 9 | 2.0 | 2.0 | 0 | 0 | 0 | -665 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.0% | 9 | 1.2 | 1.8 | 1 | 0 | 0 | 3 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 0.1% | 9 | 1.2 | 1.7 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 0.4% | 9 | 0.5 | 2.1 | 1 | 0 | 0 | -8 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.7m | 0.5% | 9 | 0.8 | 1.6 | 0 | 0 | 0 | -106 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.1% | 9 | 0.8 | 1.8 | 0 | 0 | 0 | -33 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.9% | 9 | -0.2 | 1.9 | 0 | 0 | 0 | -66 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.4% | 9 | 0.8 | 2.1 | 0 | 0 | 1 | -14 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 9 | 1.5 | 1.6 | 0 | 0 | 0 | -3 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.3m | 0.4% | 9 | 1.5 | 1.7 | 0 | 1 | 0 | 34 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.7% | 9 | 0.8 | 1.6 | 1 | 0 | 0 | -98 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.2m | 0.1% | 9 | 2.0 | 1.7 | 3 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 8 | 0.5 | 1.7 | 1 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.8m | 0.1% | 8 | 0.2 | 1.7 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.7% | 8 | 0.8 | 1.7 | 1 | 0 | 0 | -93 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 8 | 0.0 | 1.8 | 0 | 1 | 0 | -54 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.0% | 8 | 1.8 | 1.5 | 1 | 0 | 1 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.2% | 8 | 1.8 | 1.8 | 4 | 0 | 0 | 9 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.8m | 0.1% | 8 | 1.2 | 1.7 | 1 | 0 | 0 | -16 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 8 | 0.8 | 1.7 | 0 | 0 | 0 | -1 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.2% | 8 | 0.8 | 1.6 | 0 | 0 | 0 | -181 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £6.9m | 1.0% | 8 | 0.0 | 1.2 | 0 | 1 | 0 | -170 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.8m | 0.1% | 8 | 0.2 | 1.4 | 0 | 0 | 0 | -9 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £3.9m | 1.0% | 8 | 0.2 | 2.1 | 0 | 1 | 0 | -176 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 8 | 1.2 | 1.7 | 0 | 0 | 0 | -3 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.2m | 0.4% | 7 | 0.5 | 1.3 | 0 | 0 | 0 | -205 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 7 | 1.8 | 1.6 | 7 | 0 | 0 | 41 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.3m | 0.8% | 7 | 1.8 | 1.0 | 1 | 0 | 1 | 422 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.2m | 0.1% | 7 | 0.8 | 1.3 | 1 | 0 | 0 | -4 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.4% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | -64 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.3m | 0.1% | 7 | 0.0 | 1.3 | 0 | 0 | 1 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 7 | 0.8 | 1.3 | 2 | 0 | 0 | -8 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.8m | 0.1% | 7 | 0.0 | 1.5 | 1 | 1 | 0 | -20 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.7m | 0.3% | 7 | 0.2 | 1.5 | 0 | 0 | 0 | -47 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.1% | 7 | 0.2 | 1.3 | 1 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.3m | 0.0% | 7 | 0.2 | 1.3 | 0 | 0 | 1 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -16 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.0m | 0.2% | 6 | 0.5 | 1.0 | 0 | 0 | 0 | 18 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -11 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.3% | 6 | 0.8 | 1.1 | 0 | 0 | 0 | -21 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 6 | 0.5 | 1.4 | 0 | 0 | 0 | -15 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.1% | 6 | 0.2 | 1.1 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.5% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -192 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.1% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 6 | 1.2 | 1.2 | 0 | 0 | 1 | -3 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 0.0% | 6 | 1.0 | 1.1 | 0 | 0 | 0 | 2 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.0% | 6 | 1.2 | 1.1 | 0 | 0 | 0 | -13 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.2m | 0.7% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -45 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 5 | 1.0 | 1.0 | 1 | 0 | 0 | -15 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.1% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | 10 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 0.0% | 5 | 0.8 | 0.9 | 0 | 0 | 0 | 1 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.2m | 0.0% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | -2 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -8 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.1% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -15 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.4% | 5 | 0.5 | 1.3 | 0 | 0 | 0 | 62 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.0% | 5 | 0.2 | 1.3 | 1 | 0 | 0 | -156 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.1% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 5 | 0.2 | 1.0 | 1 | 0 | 1 | 30 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 5 | 0.5 | 1.1 | 1 | 0 | 0 | 1 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 5 | 0.2 | 0.9 | 0 | 0 | 0 | -14 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.2% | 4 | 0.0 | 0.7 | 0 | 0 | 0 | -32 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.7m | 0.3% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -12 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -12 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 0.1% | 4 | 0.2 | 0.8 | 0 | 0 | 0 | -8 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.4% | 4 | 0.0 | 1.0 | 0 | 0 | 0 | -98 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 5.4% | 4 | 0.2 | 0.9 | 0 | 0 | 0 | -1,142 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | -11 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.1m | 1.1% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -183 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 0.4% | 4 | 0.0 | 0.7 | 0 | 0 | 1 | -36 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.7m | 0.1% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -82 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.8m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 1.0% | 4 | 1.0 | 0.9 | 1 | 0 | 0 | -179 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.5m | 0.1% | 4 | 0.8 | 0.6 | 0 | 0 | 0 | -59 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 3.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -643 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.0% | 3 | 0.2 | 0.6 | 1 | 0 | 0 | -3 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.2m | 0.0% | 3 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.3m | 1.1% | 3 | 0.0 | 0.5 | 0 | 0 | 0 | -228 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -31 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -8 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.6% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | -42 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -16 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.2m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -92 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 3 | 0.5 | 0.6 | 1 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 0.9% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -144 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 3 | 0.5 | 0.7 | 1 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | -2 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | 9 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.0m | 0.0% | 3 | 0.5 | 0.5 | 1 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.1% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | 23 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -6 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.3m | 0.1% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -40 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.2m | 0.1% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | -21 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.1% | 2 | 0.5 | 0.4 | 1 | 0 | 0 | -38 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 6 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -5 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.5% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -87 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.2m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -87 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.4% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -60 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.0% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -3 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.5% | 2 | 0.2 | 0.5 | 1 | 0 | 0 | -63 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 2.5% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -1,201 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.3m | 0.2% | 2 | 0.2 | 0.5 | 0 | 0 | 0 | -29 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.1% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -33 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 0.2% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -62 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.9m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -43 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 1 | 0.2 | 0.2 | 1 | 0 | 0 | 242 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -7 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -9 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -39 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -41 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -47 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.8m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 21 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 33 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 4 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.0% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -9 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -231 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £3.9m | 0.2% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 37 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -38 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | -21 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -246 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 515 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -354 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -87 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.8m | 2.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -131 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -76 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 6 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -739 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -191 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -20 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £3.9m | 3.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -666 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -25 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -66 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -177 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -31 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -32 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -38 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -32 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -163 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -221 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -22 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -397 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -211 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 4.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,188 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -12 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -127 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 1.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -168 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -33 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 19 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -39 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -734 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -104 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £3.9m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -98 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -40 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -15 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -15 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -43 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -177 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -170 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -15 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 29 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -76 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.1m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -54 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 9 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 12 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 161 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -196 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -72 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -85 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -24 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -70 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -23 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -206 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £3.9m | 15.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3,308 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -171 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -212 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 11 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) |